Elite Pharmaceuticals (OTCMKTS:ELTP) Share Price Passes Below Two Hundred Day Moving Average – Time to Sell?

Elite Pharmaceuticals, Inc. (OTCMKTS:ELTP)’s stock price crossed below its two hundred day moving average during trading on Wednesday . The stock has a two hundred day moving average of $0.50 and traded as low as $0.46. Elite Pharmaceuticals shares last traded at $0.47, with a volume of 463,596 shares traded.

Elite Pharmaceuticals Stock Up 1.6 %

The company has a quick ratio of 1.90, a current ratio of 3.27 and a debt-to-equity ratio of 0.12. The company has a market capitalization of $504.27 million, a PE ratio of -23.60 and a beta of 0.14. The company’s 50 day moving average is $0.49 and its two-hundred day moving average is $0.50.

Elite Pharmaceuticals (OTCMKTS:ELTP) last issued its quarterly earnings data on Thursday, February 13th. The specialty pharmaceutical company reported ($0.01) earnings per share for the quarter. Elite Pharmaceuticals had a negative net margin of 25.70% and a negative return on equity of 6.92%.

Elite Pharmaceuticals Company Profile

Elite Pharmaceuticals, Inc, a specialty pharmaceutical company, engages in the development, manufacture, and sale of oral, controlled-release products, and generic pharmaceuticals. The company operates in two segments, Abbreviated New Drug Applications for Generic Pharmaceuticals and New Drug Applications for Branded Pharmaceuticals.